2-[(2,3-Dimethylphenyl)amino]benzoic acid;61-68-7;Spectrum5_001341;Spectrum_000174;InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18;Prestwick0_000054;BSPBio_002724;SPBio_002128;Spectrum4_001235;SPECTRUM1501103;Anthranilic acid, N-2,3-xylyl-;KBioSS_000654;KBio2_000654;KBio2_003222;KBio2_005790;MLS000069709;SMR000058188;M4267_SIGMA;KBioGR_001730;2-(2,3-Dimethylanilino)benzoic acid;AIDS-159978;AIDS159978;Benzoic acid, {2-[(2,3-dimethylphenyl)amino]-};N-(2, 3-Dimethylphenyl)anthranilic acid;{2-[(2,} 3-Dimethylphenyl)amino]benzoic acid;DivK1c_000298;BPBio1_000229;2-((2,3-Dimethylphenyl)amino)benzoic acid;2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-;AGN-1255;Ac. mefenamico [Italian];Acide mefenamique [French];Acide mefenamique [INN-French];Acido mefenamico [INN-Spanish];Acidum mefenamicum [INN-Latin];D00151;Mefenamic acid (JP15/USP/INN);Ponstel (TN);Bafameritin-M;Bafhameritin-M;Benzoic acid, 2-((2,3-dimethylphenyl)amino)-;Bonabol;CL 473;CN 35355;CN-35355;Coslan;EINECS 200-513-1;HL 1;HSDB 3115;INF 3355;Lysalgo;Mefacit;Mefedolo;Mefenamic acid [USAN:BAN:INN:JAN];Mefenaminsaeure [German];Mephenamic acid;Mephenaminic acid;Methenamic acid;Mycasaal;SGCUT00005;N-(2,3-Xylyl)-2-aminobenzoic acid;N-2,3-Xylylanthranilic acid;NSC 94437;Namphen;Parkemed;Ponalar;Ponstan;Ponstan forte;Ponstel;Rolan;Tamany Bonsan;Tanston;Vialidon;Prestwick_506;NCGC00022393-03;to_000071;NCGC00022393-04;C02168;2-[(2,3-Dimethylphenyl)amino]benzoic acid;Benzoic acid, 2-[(2,3-dimethylphenyl)amino]-;CI 473;CI-473;INF-3355;N-(2,3-Xylyl)anthranilic acid;NSC94437;Ponstil;Ponstyl;Pontal;WLN: QVR BMR B1 C1;CAS-61-68-7;NCGC00016278-01;Anthranilic acid, N-(2,3-xylyl)-;Oprea1_193889;BSPBio_000207;SMP2_000141;Prestwick3_000054;Prestwick1_000054;BRN 2216243;KBio1_000298;Spectrum2_001941;IDI1_000298;A1077/0050549;KBio3_001944;Spectrum3_001082;SPBio_002001;NINDS_000298;N-(2,3-Dimethylphenyl)anthranilic acid;UNM000001233403;Mefenamic acid;Prestwick2_000054;NCGC00022393-05
2-[(2,3-Dimethylphenyl)amino]benzoic acid